Related Experiment Video
Updated: Jun 11, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Device therapy for arrhythmia management in adults with congenital heart disease
Christopher J McLeod1, Samuel J Asirvatham, Carole A Warnes
1Division of Cardiovascular Diseases and Internal Medicine Mayo Clinic, Rochester, MN, USA.
Abstract:
The number of children with congenital heart disease surviving into adulthood has increased dramatically. Refinement in surgical techniques and effective subsequent care has mainly been responsible for this change. However, many of these survivors have significant lifestyle altering symptoms associated with rhythm disorders. These may result from the primary congenital anomaly or from surgical correction. Tachyarrhythmias often result from re-entrant circuits around surgical scars in the setting of a markedly enlarged cardiac chamber. Symptomatic bradyarrhythmias may result from surgical interruption of the conduction system or from the use of antiarrhythmic medication. The management of these lifestyle altering rhythm disorders frequently involves cardiac devices, including pacemakers, antitachycardia devices, defibrillators and resynchronization devices. We review the underlying causes for common rhythm disorders and discuss the specific challenges with cardiac device use in the adult congenital heart disease population. In addition, we address pacing for improvement of ventricular function and innovations likely to impact the field.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Heart Failure VI: Adjunct Therapies
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

